AzTrials
AzTrials

Post Intensive Care SyndromePICS3NCT05534828

Risk Factors for the Occurrence of Post Intensive Care Syndrome (PICS)

An observational study of Post Intensive Care Syndrome, run by University Hospital, Toulouse at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Monocentric, observational, descriptive RIPH3 study with prospective data collection. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Post Intensive Care Syndrome
What is being tested?
A consultation
How many people
97 participants
Where
1 siteFrance
Study dates
10 Oct 2022to 30 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: population of patients surviving a stay in polyvalent resuscitation

Who may be able to join

  • adult patient
  • hospitalized in the intensive care unit of Rangueil of the TOULOUSE University Hospital
  • length of stay in intensive care equal or superior to 24 hours
  • affiliated to a social security system
  • having expressed no objection to participate in the study

Who cannot join

  • minor patient
  • no consent to the study
  • patient not capable of expressing his "non opposition" to the study
  • patient under guardianship, curatorship or safeguard of justice

Trial locations and contacts

1 site in 1 country.

France1 site
  • University Hospital of Toulouse

    Toulouse

Other trials in France

About this study

Official title: Risk Factors for the Occurrence of Post Intensive Care Syndrome (PICS) At 3 Months After a Stay in the Rangueil Multipurpose Resuscitation Unit of the Toulouse University Hospital

Monocentric, observational, descriptive RIPH3 study with prospective data collection.

Read the detailed description

A consultation in the form of a teleconsultation with video conference is proposed to all adult patients who have stayed more than 24 hours in the Rangueil intensive care unit.

This consultation is scheduled and will take place approximately three months after the end of the stay in the intensive care unit.

During this consultation, signs will be sought through questioning to detect or even diagnose the presence of a PICS.

We will also look for elements that will allow us to characterize people with CHIP.

If a PICS was detected during the consultation, the summary letter sent to the attending physician informs him/her of

  1. The presence of a CHIP in his patient
  2. The nature of this CHIP (CHIP with a purely psychological component, CHIP with a psychological and physical component, etc.) In this same summary letter, the attending physician will be offered a list of specialists practicing at the CHU who are likely to take charge of the patient's CHIP.
Being tested
A consultation
Medical subject headings
postintensive care syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A consultationDiagnostic test

    A consultation at three months of discharge from the intensive care unit in the population of patients surviving a multivalent intensive care unit stay

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence at 3 months of PICS

    Incidence at 3 months of PICS as defined below:

    A PICS is defined as ''present'' at the 3-month visit if the patient has one or more of the following:

    • Impaired quality of life as defined by a 5D5L EQ score greater than or equal to 3 on at least 1 dimension of the questionnaire.
    • Anxiety symptoms defined by a HADS anxiety score greater than or equal to 11.
    • Depressive symptoms defined by a HADS depression score greater than or equal to 11.
    • Symptoms of post-traumatic stress defined by a PCL 5 score greater than or equal to 33.
    • Symptoms of undernutrition defined by an NRS score greater than or equal to 3.
    • Pain symptoms defined by a DN4 score greater than or equal to 4 and/or an EVS score greater than or equal to 4.

    Measured: month 3

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2022
  2. Study start10 Oct 2022
  3. Primary completion30 Jun 2023
  4. Study completion30 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
97 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05534828
Sponsor's protocol ID
RC31/22/0215
Other IDs
2022-A01371-42
Acronym
PICS3
Status last verified
Sep 2024
First submitted
6 Sep 2022
Last updated
25 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Post Intensive Care Syndrome, run by University Hospital, Toulouse at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence at 3 months of PICS (time frame: month 3). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2024; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in